Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Lennox-Gastaut Syndrome Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Non-surgical Treatment 1.4.3 Surgical Treatment 1.5 Market by Application 1.5.1 Global Lennox-Gastaut Syndrome Treatment Market Share by Application: 2020 VS 2026 1.5.2 Seizures 1.5.3 Ocular Abnormality 1.5.4 EEG Findings 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Lennox-Gastaut Syndrome Treatment Market Perspective (2015-2026) 2.2 Lennox-Gastaut Syndrome Treatment Growth Trends by Regions 2.2.1 Lennox-Gastaut Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Lennox-Gastaut Syndrome Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Lennox-Gastaut Syndrome Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Lennox-Gastaut Syndrome Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Lennox-Gastaut Syndrome Treatment Players by Market Size 3.1.1 Global Top Lennox-Gastaut Syndrome Treatment Players by Revenue (2015-2020) 3.1.2 Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Lennox-Gastaut Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio 3.2.1 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Lennox-Gastaut Syndrome Treatment Revenue in 2019 3.3 Lennox-Gastaut Syndrome Treatment Key Players Head office and Area Served 3.4 Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service 3.5 Date of Enter into Lennox-Gastaut Syndrome Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Lennox-Gastaut Syndrome Treatment Historic Market Size by Type (2015-2020) 4.2 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Type (2021-2026) 5 Lennox-Gastaut Syndrome Treatment Breakdown Data by Application (2015-2026) 5.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 5.2 Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 6.2 Lennox-Gastaut Syndrome Treatment Key Players in North America (2019-2020) 6.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 6.4 North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 7.2 Lennox-Gastaut Syndrome Treatment Key Players in Europe (2019-2020) 7.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 7.4 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 8 China 8.1 China Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 8.2 Lennox-Gastaut Syndrome Treatment Key Players in China (2019-2020) 8.3 China Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 8.4 China Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 9.2 Lennox-Gastaut Syndrome Treatment Key Players in Japan (2019-2020) 9.3 Japan Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 9.4 Japan Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 10.2 Lennox-Gastaut Syndrome Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 11 India 11.1 India Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 11.2 Lennox-Gastaut Syndrome Treatment Key Players in India (2019-2020) 11.3 India Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 11.4 India Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Lennox-Gastaut Syndrome Treatment Market Size (2015-2020) 12.2 Lennox-Gastaut Syndrome Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) 12.4 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Eisai Co., Ltd. 13.1.1 Eisai Co., Ltd. Company Details 13.1.2 Eisai Co., Ltd. Business Overview and Its Total Revenue 13.1.3 Eisai Co., Ltd. Lennox-Gastaut Syndrome Treatment Introduction 13.1.4 Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020)) 13.1.5 Eisai Co., Ltd. Recent Development 13.2 GlaxoSmithKline plc. 13.2.1 GlaxoSmithKline plc. Company Details 13.2.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue 13.2.3 GlaxoSmithKline plc. Lennox-Gastaut Syndrome Treatment Introduction 13.2.4 GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) 13.2.5 GlaxoSmithKline plc. Recent Development 13.3 H. Lundbeck A/S 13.3.1 H. Lundbeck A/S Company Details 13.3.2 H. Lundbeck A/S Business Overview and Its Total Revenue 13.3.3 H. Lundbeck A/S Lennox-Gastaut Syndrome Treatment Introduction 13.3.4 H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) 13.3.5 H. Lundbeck A/S Recent Development 13.4 Johnson & Johnson Services, Inc. 13.4.1 Johnson & Johnson Services, Inc. Company Details 13.4.2 Johnson & Johnson Services, Inc. Business Overview and Its Total Revenue 13.4.3 Johnson & Johnson Services, Inc. Lennox-Gastaut Syndrome Treatment Introduction 13.4.4 Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) 13.4.5 Johnson & Johnson Services, Inc. Recent Development 13.5 Supernus Pharmaceuticals, Inc 13.5.1 Supernus Pharmaceuticals, Inc Company Details 13.5.2 Supernus Pharmaceuticals, Inc Business Overview and Its Total Revenue 13.5.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Introduction 13.5.4 Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) 13.5.5 Supernus Pharmaceuticals, Inc Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Lennox-Gastaut Syndrome Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Lennox-Gastaut Syndrome Treatment Revenue Table 3. Ranking of Global Top Lennox-Gastaut Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Non-surgical Treatment Table 6. Key Players of Surgical Treatment Table 7. Global Lennox-Gastaut Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2015-2020) Table 11. Global Lennox-Gastaut Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Lennox-Gastaut Syndrome Treatment Market Growth Strategy Table 17. Main Points Interviewed from Key Lennox-Gastaut Syndrome Treatment Players Table 18. Global Lennox-Gastaut Syndrome Treatment Revenue by Players (2015-2020) (Million US$) Table 19. Global Lennox-Gastaut Syndrome Treatment Market Share by Players (2015-2020) Table 20. Global Top Lennox-Gastaut Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2019) Table 21. Global Lennox-Gastaut Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Lennox-Gastaut Syndrome Treatment Product Solution and Service Table 24. Date of Enter into Lennox-Gastaut Syndrome Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 27. Global Lennox-Gastaut Syndrome Treatment Market Size Share by Type (2015-2020) Table 28. Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Lennox-Gastaut Syndrome Treatment Market Size Share by Application (2015-2020) Table 30. Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 31. Global Lennox-Gastaut Syndrome Treatment Market Size Share by Application (2021-2026) Table 32. North America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 33. North America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 34. North America Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 35. North America Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 36. North America Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 37. North America Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 38. Europe Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 40. Europe Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 41. Europe Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 42. Europe Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 43. Europe Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 44. China Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 45. China Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 46. China Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 47. China Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 48. China Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 49. China Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 50. Japan Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 52. Japan Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 53. Japan Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 54. Japan Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 55. Japan Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 58. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 60. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 62. India Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 63. India Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 64. India Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 65. India Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 66. India Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 67. India Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 68. Central & South America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2019-2020) Table 70. Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Type (2015-2020) Table 72. Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Application (2015-2020) Table 74. Eisai Co., Ltd. Company Details Table 75. Eisai Co., Ltd. Business Overview Table 76. Eisai Co., Ltd. Product Table 77. Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) (Million US$) Table 78. Eisai Co., Ltd. Recent Development Table 79. GlaxoSmithKline plc. Company Details Table 80. GlaxoSmithKline plc. Business Overview Table 81. GlaxoSmithKline plc. Product Table 82. GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) (Million US$) Table 83. GlaxoSmithKline plc. Recent Development Table 84. H. Lundbeck A/S Company Details Table 85. H. Lundbeck A/S Business Overview Table 86. H. Lundbeck A/S Product Table 87. H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) (Million US$) Table 88. H. Lundbeck A/S Recent Development Table 89. Johnson & Johnson Services, Inc. Company Details Table 90. Johnson & Johnson Services, Inc. Business Overview Table 91. Johnson & Johnson Services, Inc. Product Table 92. Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) (Million US$) Table 93. Johnson & Johnson Services, Inc. Recent Development Table 94. Supernus Pharmaceuticals, Inc Company Details Table 95. Supernus Pharmaceuticals, Inc Business Overview Table 96. Supernus Pharmaceuticals, Inc Product Table 97. Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2015-2020) (Million US$) Table 98. Supernus Pharmaceuticals, Inc Recent Development Table 99. Research Programs/Design for This Report Table 100. Key Data Information from Secondary Sources Table 101. Key Data Information from Primary Sources List of Figures Figure 1. Global Lennox-Gastaut Syndrome Treatment Market Share by Type: 2020 VS 2026 Figure 2. Non-surgical Treatment Features Figure 3. Surgical Treatment Features Figure 4. Global Lennox-Gastaut Syndrome Treatment Market Share by Application: 2020 VS 2026 Figure 5. Seizures Case Studies Figure 6. Ocular Abnormality Case Studies Figure 7. EEG Findings Case Studies Figure 8. Others Case Studies Figure 9. Lennox-Gastaut Syndrome Treatment Report Years Considered Figure 10. Global Lennox-Gastaut Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Lennox-Gastaut Syndrome Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Lennox-Gastaut Syndrome Treatment Market Share by Players in 2019 Figure 15. Global Top Lennox-Gastaut Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lennox-Gastaut Syndrome Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Lennox-Gastaut Syndrome Treatment Revenue in 2019 Figure 17. North America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Lennox-Gastaut Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Eisai Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Eisai Co., Ltd. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2015-2020) Figure 26. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. GlaxoSmithKline plc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2015-2020) Figure 28. H. Lundbeck A/S Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. H. Lundbeck A/S Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2015-2020) Figure 30. Johnson & Johnson Services, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Johnson & Johnson Services, Inc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2015-2020) Figure 32. Supernus Pharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Supernus Pharmaceuticals, Inc Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2015-2020) Figure 34. Bottom-up and Top-down Approaches for This Report Figure 35. Data Triangulation Figure 36. Key Executives Interviewed

Eisai Co., Ltd. GlaxoSmithKline plc. H. Lundbeck A/S Johnson & Johnson Services, Inc. Supernus Pharmaceuticals, Inc